Edition:
United Kingdom

Zhejiang Hisun Pharmaceutical Co Ltd (600267.SS)

600267.SS on Shanghai Stock Exchange

10.16CNY
20 Aug 2019
Change (% chg)

¥-0.04 (-0.39%)
Prev Close
¥10.20
Open
¥10.26
Day's High
¥10.41
Day's Low
¥10.10
Volume
13,200,991
Avg. Vol
11,054,907
52-wk High
¥13.77
52-wk Low
¥7.71

Latest Key Developments (Source: Significant Developments)

Zhejiang Hisun Pharmaceutical To Boost Biomedical Unit's Capital, Another Unit To Sell Property
Friday, 21 Jun 2019 

June 21 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>::SAYS IT PLANS TO BOOST BIOMEDICAL UNIT'S CAPITAL BY AT LEAST 1.0 BILLION YUAN ($145.54 million) BY BRINGING IN INVESTORS.SAYS IT PLANS TO SELL SHARES IN BIOMEDICAL UNIT FOR AT LEAST 2.8 BILLION YUAN.SAYS UNIT PLANS TO SELL PROPERTY FOR AT LEAST 290 MILLION YUAN.  Full Article

Zhejiang Hisun Pharmaceutical To Sell 20.24% Stake In Pharmaceutical Technology Firm
Wednesday, 29 May 2019 

May 29 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>::SAYS IT PLANS TO SELL 20.24% STAKE IN PHARMACEUTICAL TECHNOLOGY FIRM FOR AT LEAST 138.4 MILLION YUAN ($20.03 million).  Full Article

Zhejiang Hisun Pharmaceutical receives GMP certificates
Monday, 7 May 2018 

May 7 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says it received goods manufacture practice (GMP) certificates from Zhejiang Food and Drug Administration .Certificate issued to crude drugs and antineoplastic drugs manufactured by the company and the valid period is until 2023 .  Full Article

Zhejiang Hisun Pharmaceutical to pay cash dividend of 0.5 yuan (pre-tax) for every 10 shares
Wednesday, 28 Mar 2018 

March 28 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says it plans to pay a cash dividend of 0.5 yuan (pre-tax) for every 10 shares as the dividend payment plan for 2017.  Full Article

Zhejiang Hisun Pharmaceutical to swing to profit in FY 2017
Wednesday, 31 Jan 2018 

Jan 31 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS> ::Sees to swing to net profit at 10 million yuan to 15 million yuan in FY 2017 versus net loss at 94.4 million yuan year ago.Says growth of main business and received compensation as well as government subsidies as main reasons for the forecast.  Full Article

Zhejiang Hisun Pharmaceutical and unit obtain high-tech enterprise recognition and to enjoy tax preference
Thursday, 4 Jan 2018 

Jan 4(Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says it and unit were recognized as high-tech enterprise, and to enjoy a tax preference of 15 percent for three years .  Full Article

Zhejiang Hisun Pharmaceutical passes FDA approval
Tuesday, 21 Nov 2017 

Nov 21(Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says it received approval for a kind of tablet from U.S Food and Drug Administration .  Full Article

Zhejiang Hisun Pharmaceutical unit says product gets FDA approval
Monday, 20 Nov 2017 

Nov 20(Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says co's Hangzhou-based unit's product simvastatin tablets, gets approval from U.S. Food and Drug Administration.  Full Article

Zhejiang Hisun Pharmaceutical says product gets FDA approval
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS> ::Says its product, mycophenolate mofetil capsules, gets approval from U.S. Food and Drug Administration .  Full Article

Zhejiang Hisun Pharmaceutical says change of CFO
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS> ::Says it appoints Liu Yuanyan as new CFO, replacing Guan Xuhua who resigns from the position due to internal change in job role.  Full Article